Loading company…
Neuvivo develops therapies for neurological diseases, including amyotrophic lateral sclerosis.
Neuvivo is a biopharmaceutical company developing therapies for neurological diseases such as amyotrophic lateral sclerosis. Founded in 2020 and based in California, US, it is at a late clinical stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in